PBYI - Puma Biotechnology, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PBYI (1401667)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
40 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-09-04
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$10.14-5244,188,4840%-$5,313
2019-09-04
PBYIBryce Richard PaulSEE REMARKSS - Sale$10.11-9536,7170%-$960
2019-08-02
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$9.03-5174,189,0080%-$4,668
2019-08-02
PBYIBryce Richard PaulSEE REMARKSS - Sale$9.00-9436,8120%-$846
2019-07-22
PBYILo StevenChief Commercial OfficerS - Sale$10.04-1,85219,557-9%-$18,600
2019-07-22
PBYIBryce Richard PaulSEE REMARKSS - Sale$10.10-1,84136,906-5%-$18,589
2019-07-22
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$9.98-12,7154,189,5250%-$126,846
2019-07-02
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$12.78-4954,202,2400%-$6,326
2019-07-02
PBYIBryce Richard PaulSEE REMARKSS - Sale$12.78-8938,7470%-$1,137
2019-06-03
PBYIBryce Richard PaulSEE REMARKSS - Sale$15.07-8838,8360%-$1,326
2019-06-03
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$15.18-4834,202,7350%-$7,332
2019-05-02
PBYIBryce Richard PaulSEE REMARKSS - Sale$32.38-8538,9240%-$2,752
2019-05-02
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$32.38-4774,203,2180%-$15,445
2019-04-02
PBYIBryce Richard PaulSEE REMARKSS - Sale$35.78-8839,0090%-$3,149
2019-04-02
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$35.79-4914,203,6950%-$17,573
2019-03-04
PBYIBryce Richard PaulSEE REMARKSS - Sale$38.66-8839,0970%-$3,402
2019-03-04
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$38.62-4964,204,1860%-$19,156
2019-02-04
PBYIEyler Charles RSEE REMARKSS - Sale$27.64-8731,9570%-$2,405
2019-02-04
PBYIBryce Richard PaulSEE REMARKSS - Sale$27.77-8929,2850%-$2,472
2019-02-04
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$27.80-3454,165,4670%-$9,591
2019-01-22
PBYILo StevenChief Commercial OfficerS - Sale$24.91-2,11421,409-9%-$52,664
2019-01-22
PBYIEyler Charles RSEE REMARKSS - Sale$24.80-71332,044-2%-$17,682
2019-01-22
PBYIBryce Richard PaulSEE REMARKSS - Sale$24.72-1,95929,374-6%-$48,426
2019-01-22
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$24.74-8,8254,165,8120%-$218,334
2019-01-03
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$20.67-4,4244,174,6370%-$91,444
2019-01-03
PBYIEyler Charles RSEE REMARKSS - Sale$20.67-1,21032,757-4%-$25,011
2019-01-03
PBYIBryce Richard PaulSEE REMARKSS - Sale$20.67-1,21031,333-4%-$25,011
2018-12-03
PBYIEyler Charles RSEE REMARKSS - Sale$22.77-1,23933,967-4%-$28,212
A
2018-01-22
PBYIEyler Charles RSEE REMARKSS - Sale$92.85-66928,027-2%-$62,117
2018-07-20
PBYILo StevenChief Commercial OfficerS - Sale$51.85-1,83923,523-7%-$95,360
2018-07-20
PBYIEyler Charles RSEE REMARKSS - Sale$51.95-61035,206-2%-$31,690
2018-07-20
PBYIBryce Richard PaulSEE REMARKSS - Sale$51.95-1,83632,543-5%-$95,381
2018-07-20
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$52.00-12,5204,179,0610%-$651,020
2018-06-01
PBYIEyler Charles RSEE REMARKSS - Sale$53.00-1,21135,816-3%-$64,183
2018-01-22
PBYILo StevenChief Commercial OfficerS - Sale$92.85-1,85825,362-7%-$172,515
2018-01-22
PBYIEyler Charles RSEE REMARKSS - Sale$92.85-66928,027-2%-$62,117
2018-01-22
PBYIBryce Richard PaulSVP, CLINICAL RESEARCH, DEVS - Sale$92.75-1,86025,379-7%-$172,515
2018-01-22
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$92.75-10,6924,155,9310%-$991,683
2017-12-01
PBYIEyler Charles RSEE REMARKSS - Sale$105.47-1,32228,696-4%-$139,424
D
2017-09-29
PBYIBryce Richard PaulSVP, CLINICAL RESEARCH, DEVS - Sale+OE$120.00-15,00027,239-36%-$1,800,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top